Journal of drug targeting

Keyphrases

Publications

volume 32, number 4, 2024

Ruohong Wang, Suyun Rao, Zheng Zhong, Ke Xiao, Xuhui Chen, Xufang Sun
Emerging role of ferroptosis in diabetic retinopathy: a review. Journal of drug targeting 32 (4) (2024)
Maha Ali Alghamdi, Mohamed Haider, Sebastiano Intagliata, Valeria Pittalà, Jayalakshmi Jagal, Youssef Haider, Nasneen Althaf, Khaled Greish
Lauric acid-based thermosensitive delivery system for the treatment of head and neck squamous cell carcinoma. Journal of drug targeting 32 (4) (2024)
Emma Frouhar, Arghavan Adibifar, Maryam Salimi, Zahra Karami, Nasim Shadmani, Kobra Rostamizadeh
Novel pH-responsive alginate-stabilized curcumin-selenium-ZIF-8 nanocomposites for synergistic breast cancer therapy. Journal of drug targeting 32 (4) (2024)
Charlene Priscilla Poore, Shunhui Wei, Bo Chen, See Wee Low, Jeslyn Si Qi Tan, Andy Thiam-Huat Lee, Bernd Nilius, Ping Liao
In vivo evaluation of monoclonal antibody M4M using a humanised rat model of stroke demonstrates attenuation of reperfusion injury via blocking human TRPM4 channel. Journal of drug targeting 32 (4) (2024)
Omkar T Khaire, Akshada Mhaske, Aprameya Ganesh Prasad, Waleed H Almalki, Nidhi Srivastava, Prashant Kesharwani, Rahul Shukla
State-of-the-art drug delivery system to target the lymphatics. Journal of drug targeting 32 (4) (2024)

volume 32, number 5, 2024

Yaya Wei, Jueshuo Guo, Tingting Meng, Ting Gao, Yaping Mai, Wenbao Zuo, Jianhong Yang
The potential application of complement inhibitors-loaded nanosystem for autoimmune diseases via regulation immune balance. Journal of drug targeting 32 (5) (2024)
Kresimir Tomic, Kristina Krpina, Lara Baticic, Miroslav Samarzija, Semir Vranic
Comprehensive molecular and clinical insights into non-small cell lung cancer transformation to small cell lung cancer with an illustrative case report. Journal of drug targeting 32 (5) (2024)
Chang Liu, Yuanyuan Zhang, Jing Wen, Ji Liu, Meirong Huo, Yan Shen, Hao Luo, Hui Zhang
Red blood membrane camouflaging Bismuth nanoflowers designed for radio-photothermal therapy in lung cancer. Journal of drug targeting 32 (5) (2024)
Nitin Sharma, Balak Das Kurmi, Dilpreet Singh, Sidharth Mehan, Kushagra Khanna, Ritu Karwasra, Shobhit Kumar, Amit Chaudhary, Vikash Jakhmola, Anjana Sharma, Sachin Kumar Singh, Kamal Dua, Dipti Kakkar
Nanoparticles toxicity: an overview of its mechanism and plausible mitigation strategies. Journal of drug targeting 32 (5) (2024)
Can Wang, Yihang Yang, Ruming Liang, Shikui Wu, Chengrui Xuan, Wei Lv, Jian Li
Preparation and anti-inflammatory effect of mercury sulphide nanoparticle-loaded hydrogels. Journal of drug targeting 32 (5) (2024)
Unnati Garg, Tanya Dua, Shreya Kaul, Neha Jain, Manisha Pandey, Upendra Nagaich
Enhancing periodontal defences with nanofiber treatment: recent advances and future prospects. Journal of drug targeting 32 (5) (2024)
Rui Zou, Yunhe Hao, Chunchun Qi, Xu Peng, Zepeng Huang, Duo Li, Yiyao Wang
Trimethyl chitosan-cysteine-based nanoparticles as an effective delivery system for portulacerebroside A in the management of hepatocellular carcinoma cells in vitro and in vivo . Journal of drug targeting 32 (5) (2024)
Unnati Garg, Tanya Dua, Shreya Kaul, Neha Jain, Manisha Pandey, Upendra Nagaich
Enhancing periodontal defences with nanofiber treatment: recent advances and future prospects. Journal of drug targeting 32 (5) (2024)
Kresimir Tomic, Kristina Krpina, Lara Baticic, Miroslav Samarzija, Semir Vranic
Comprehensive molecular and clinical insights into non-small cell lung cancer transformation to small cell lung cancer with an illustrative case report. Journal of drug targeting 32 (5) (2024)
Nitin Sharma, Balak Das Kurmi, Dilpreet Singh, Sidharth Mehan, Kushagra Khanna, Ritu Karwasra, Shobhit Kumar, Amit Chaudhary, Vikash Jakhmola, Anjana Sharma, Sachin Kumar Singh, Kamal Dua, Dipti Kakkar
Nanoparticles toxicity: an overview of its mechanism and plausible mitigation strategies. Journal of drug targeting 32 (5) (2024)
Anjali Bisht, Shuvadip Bhowmik, Preeti Patel, Ghanshyam Das Gupta, Balak Das Kurmi
Aptamer as a targeted approach towards treatment of breast cancer. Journal of drug targeting 32 (5) (2024)
Xingyu Zou, Yue Liu, Mengyao Cui, Qing Wan, Xiaoqin Chu
The in vitro intestinal cell model: different co-cultured cells create different applications. Journal of drug targeting 32 (5) (2024)
Yaya Wei, Jueshuo Guo, Tingting Meng, Ting Gao, Yaping Mai, Wenbao Zuo, Jianhong Yang
The potential application of complement inhibitors-loaded nanosystem for autoimmune diseases via regulation immune balance. Journal of drug targeting 32 (5) (2024)
Anjali Bisht, Shuvadip Bhowmik, Preeti Patel, Ghanshyam Das Gupta, Balak Das Kurmi
Aptamer as a targeted approach towards treatment of breast cancer. Journal of drug targeting 32 (5) (2024)
Xingyu Zou, Yue Liu, Mengyao Cui, Qing Wan, Xiaoqin Chu
The in vitro intestinal cell model: different co-cultured cells create different applications. Journal of drug targeting 32 (5) (2024)

volume 32, number 6, 2024

Chenglong Li, Yan Li, Qing Zeng, Yang Zhou, Huaiyu Su, Yangyun Han, Chen Li
Celastrol nano-emulsions selectively regulate apoptosis of synovial macrophage for alleviating rheumatoid arthritis. Journal of drug targeting 32 (6) (2024)
Bingyu Wang, Liuxin Yang, Xingxing Yuan, Yang Zhang
Roles and therapeutic targeting of dendritic cells in liver fibrosis. Journal of drug targeting 32 (6) (2024)
Shaban Ahmad, Khalid Raza
An extensive review on lung cancer therapeutics using machine learning techniques: state-of-the-art and perspectives. Journal of drug targeting 32 (6) (2024)
Lijuan Liang, Yiping Deng, Zuojin Ao, Changli Liao, Ji Tian, Chunhong Li, Xin Yu
Recent progress in biomimetic nanomedicines based on versatile targeting strategy for atherosclerosis therapy. Journal of drug targeting 32 (6) (2024)
Muhammad Ahsan Waqar, Muhammad Zaman, Rabeel Khan, Muhammad Shafeeq Ur Rahman, Imtiaz Majeed
Navigating the tumor microenvironment: mesenchymal stem cell-mediated delivery of anticancer agents. Journal of drug targeting 32 (6) (2024)
Syeda Nashvia Adin, Isha Gupta, Mohd Aqil, Mohd Mujeeb, Abul Kalam Najmi
Synergistically engineered nanotransethosomes for co-delivery of methotrexate and baicalin for enhanced transdermal delivery against rheumatoid arthritis: formulation, characterisation and in vivo pharmacodynamic evaluation. Journal of drug targeting 32 (6) (2024)
Khent Primo Alcantara, John Wilfred T Malabanan, Opa Vajragupta, Pornchai Rojsitthisak, Pranee Rojsitthisak
A promising strategy of surface-modified nanoparticles targeting CXCR4 for precision cancer therapy. Journal of drug targeting 32 (6) (2024)
Henglai Sun, Xinyu Li, Qian Liu, Huagang Sheng, Liqiao Zhu
pH-responsive self-assembled nanoparticles for tumor-targeted drug delivery. Journal of drug targeting 32 (6) (2024)
Muhammad Ahsan Waqar, Naeem Mubarak, Asad Majeed Khan, Rabeel Khan, Farwa Shaheen, Afshan Shabbir
Advanced polymers and recent advancements on gastroretentive drug delivery system; a comprehensive review. Journal of drug targeting 32 (6) (2024)

volume 32, number 7, 2024

Kriti Kushwaha, Sourbh Suren Garg, Debojyoti Mandal, Navneet Khurana, Jeena Gupta
Screening of natural epigenetic modifiers for managing glycemic memory and diabetic nephropathy. Journal of drug targeting 32 (7) (2024)
Aprameya Prasad, Mohamed Mofreh Bakr, Aliaa Nabil ElMeshad
Surface-functionalised polymeric nanoparticles for breast cancer treatment: processes and advances. Journal of drug targeting 32 (7) (2024)
Ting Yang, Zihan Liu, Tong Zhang, Yanhua Liu
Hybrid nano-stimulator for specific amplification of oxidative stress and precise tumour treatment. Journal of drug targeting 32 (7) (2024)
Hadiseh Mehravanfar, Nafiseh Farhadian, Khalil Abnous
Indocyanine green-loaded N-doped carbon quantum dot nanoparticles for effective photodynamic therapy and cell imaging of melanoma cancer: in vitro , ex vivo and in vivo study. Journal of drug targeting 32 (7) (2024)
Susbin Raj Wagle, Bozica Kovacevic, Thomas Foster, Corina Mihaela Ionescu, Melissa Jones, Momir Mikov, Andrew Wise, Armin Mooranian, Hani Al-Salami
Probucol-bile acid nanoparticles: a novel approach and promising solution to prevent cellular oxidative stress in sensorineural hearing loss. Journal of drug targeting 32 (7) (2024)
Si-Qi Yang, Xi Zhao, Jing Zhang, Dong-Ying Liao, Yu-Han Wang, Yao-Guang Wang
Ferroptosis in renal fibrosis: a mini-review. Journal of drug targeting 32 (7) (2024)
Tomoaki Kurosaki, Yuki Ueda, Yuka Kato, Mikiro Nakashima, Takashi Kitahara, Hitoshi Sasaki, Yukinobu Kodama
Effect of a novel siRNA delivery system, siRNA ternary complex, on melanoma lung metastasis. Journal of drug targeting 32 (7) (2024)
Sarvenaz Kashefi, Samira Mohammadi-Yeganeh, Fatemeh Ghorbani-Bidkorpeh, Mahdi Shabani, Ameneh Koochaki, Mostafa Haji Molla Hoseini
The anti-cancer properties of miR-340 plasmid-chitosan complexes (miR-340 CC) on murine model of breast cancer. Journal of drug targeting 32 (7) (2024)
Mehdi Yoosefian, Hanieh Sabaghian
Silver nanoparticle-based drug delivery systems in the fight against COVID-19: enhancing efficacy, reducing toxicity and improving drug bioavailability. Journal of drug targeting 32 (7) (2024)

volume 32, number 8, 2024

Clelia Di Salvo, Vanessa D'Antongiovanni, Laura Benvenuti, Matteo Fornai, Giulia Valdiserra, Gianfranco Natale, Larisa Ryskalin, Elena Lucarini, Lorenzo Di Cesare Mannelli, Carla Ghelardini, Rocchina Colucci, György Haskó, Carolina Pellegrini, Luca Antonioli
The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis. Journal of drug targeting 32 (8) (2024)
Clelia Di Salvo, Vanessa D'Antongiovanni, Laura Benvenuti, Matteo Fornai, Giulia Valdiserra, Gianfranco Natale, Larisa Ryskalin, Elena Lucarini, Lorenzo Di Cesare Mannelli, Carla Ghelardini, Rocchina Colucci, György Haskó, Carolina Pellegrini, Luca Antonioli
The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis. Journal of drug targeting 32 (8) (2024)
Qi Wu, Jiangting Yao, Mengyun Xiao, Xiawei Zhang, Mengxiao Zhang, Xinting Xi
Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases. Journal of drug targeting 32 (8) (2024)
Magham Sai Varshini, Ramakkamma Aishwarya Reddy, Praveen Thaggikuppe Krishnamurthy
Unlocking hope: GSK-3 inhibitors and Wnt pathway activation in Alzheimer's therapy. Journal of drug targeting 32 (8) (2024)
Mohammed Ageeli Hakami
Harnessing machine learning potential for personalised drug design and overcoming drug resistance. Journal of drug targeting 32 (8) (2024)
Prexa Jain, Shreni Parikh, Paresh Patel, Shreeraj Shah, Kaushika Patel
Comprehensive insights into herbal P-glycoprotein inhibitors and nanoformulations for improving anti-retroviral therapy efficacy. Journal of drug targeting 32 (8) (2024)
Mariam Zewail, Haidy Abbas, Nesrine El Sayed, Heba Abd-El-Azim
Combined photodynamic therapy and hollow microneedle approach for effective non-invasive delivery of hypericin for the management of imiquimod-induced psoriasis. Journal of drug targeting 32 (8) (2024)
Yangcheng He, Yuyi Feng, Danxai Qiu, MinHua Lin, Hai Jin, Zhiwen Hu, Xue Huang, Suihong Ma, Yan He, Meiqi Lai, Wenhui Jin, Jianhua Liu
Regulation of IFP in solid tumours through acoustic pressure to enhance infiltration of nanoparticles of various sizes. Journal of drug targeting 32 (8) (2024)
Prexa Jain, Shreni Parikh, Paresh Patel, Shreeraj Shah, Kaushika Patel
Comprehensive insights into herbal P-glycoprotein inhibitors and nanoformulations for improving anti-retroviral therapy efficacy. Journal of drug targeting 32 (8) (2024)
Anju Xiao, Li Yin, Ting Chen, Huiling Qian
Lipo/TK-CDN/TPP/Y6 nanoparticles inhibit cutaneous melanoma formation. Journal of drug targeting 32 (8) (2024)
Qi Wu, Jiangting Yao, Mengyun Xiao, Xiawei Zhang, Mengxiao Zhang, Xinting Xi
Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases. Journal of drug targeting 32 (8) (2024)
Nida Nehal, Aashish Rohilla, Ali Sartaj, Sanjula Baboota, Javed Ali
Folic acid modified precision nanocarriers: charting new frontiers in breast cancer management beyond conventional therapies. Journal of drug targeting 32 (8) (2024)